vimarsana.com

Page 2 - Max Planck Institute For Metabolism Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study: Anti-Obesity Medication Normalizes Sensory Learning for Those With Obesity

Investigators aimed to determine whether liraglutide, an anti-obesity medication, could impact the learning process for individuals who had reduced insulin sensitivity due to obesity.

Anti-obesity drug improves associative learning in people with obesity: Liraglutide benefits brain activity in people with obesity

Anti-obesity drug improves associative learning in people with obesity: Liraglutide benefits brain activity in people with obesity
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

Anti-Obesity Drug Liraglutide Enhances Associative Learning!

Intake of anti-obesity drug liraglutide, resulted in better brain activity and in-turn finer associative learning in obese individuals.

Obesity impairs brain s ability to learn associations

To control our behavior, the brain must be able to form associations. This involves, for example, associating a neutral external stimulus with a consequence following the stimulus (e.g., the hotplate glows red - you can burn your hand).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.